Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Clin Cancer Res. 2020 Jan 14;26(8):2011–2021. doi: 10.1158/1078-0432.CCR-19-2884

Figure 5:

Figure 5:

Differential in vitro responsiveness of PNET cell lines to anti-cancer drugs suggested by the metastatic gene signature in patient PNETs. BON-1 (closed circles) and QGP1 (open circles) cells were exposed to increasing concentrations of the indicated drugs for five days. The proportion of viable cells is shown on the y-axis, with the dosage on the x-axis. The IC50 values (μM) are denoted for each drug.